| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |